Pancreatic Cancer Research

ResearcherUniversity of CambridgeActive in the last 2 years

David Fairen‐Jiménez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5013-1194; OpenAlex author ID A5081651773. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Rational Design of Metal-Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy. Last author DOI 10.1002/adma.202412757↗
  2. Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. Co-author DOI 10.1039/d2nr00864e↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Francesca Melle · 2 shared papers, 2022–2025 · strength 0.38
  2. João Conde · 1 shared paper, 2025 · strength 0.25
  3. Andrea Bistrović · 1 shared paper, 2022 · strength 0.14
  4. Ljiljana Fruk · 1 shared paper, 2022 · strength 0.14
  5. Frances M. Richards · 1 shared paper, 2022 · strength 0.14
  6. Duncan Ian Jodrell · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.